Newswire (Published: Tuesday, January 31, 2017, Received: Thursday, January 26, 2017, 9:26:44 PM CST)

Word Count: 441

Researchers at University of Western Ontario Release New Data on Prostate Cancer (The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA)

By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Prostate Cancer have been published. According to news reporting originating from London, Canada, by NewsRx correspondents, research stated, "Guidelines regarding recommendations for PSA screening for early detection of prostate cancer are conflicting. In 2012, the United States Preventive Services Task Force (USPSTF) assigned a grade of D (recommending against screening) for men aged greater than or equal to75 years in 2008 and for men of all ages in 2012."

Our news editors obtained a quote from the research from the University of Western Ontario, "Understanding temporal trends in rates of screening before and after the 2012 recommendation in terms of usage patterns in PSA screening, changes in prostate cancer incidence and biopsy patterns, and how the recommendation has influenced physician's and men's attitudes about PSA screening and subsequent ordering of other screening tests is essential within the scope of prostate cancer screening policy. Since the 2012 recommendation, rates of PSA screening decreased by 3-10% in all age groups and across most geographical regions of the USA. Rates of prostate biopsy and prostate cancer incidence have declined in unison, with a shift towards tumours being of higher grade and stage upon detection. Despite the recommendation, some physicians report ongoing willingness to screen appropriately selected men, and many men report intending to continue to ask for the PSA test from their physician."

According to the news editors, the research concluded: "In the coming years, we expect to have an improved understanding of whether these decreased rates of screening will affect prostate cancer metastasis and mortality."

For more information on this research see: The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA. Nature Reviews Urology, 2016;():. (Nature Publishing Group - www.nature.com/; Nature Reviews Urology - www.nature.com/nrurol/)

The news editors report that additional information may be obtained by contacting K. Fleshner, Schulich School of Medicine and Dentistry, University of Western Ontario, 1151 Richmond Street, London, Ontario N6A 5C1, Canada. Additional authors for this research include S.V. Carlsson and M.J Roobol (see also Oncology - Prostate Cancer).

Keywords for this news article include: London, Canada, Ontario, Oncology, Article Review, Prostate Cancer, Prostatic Neoplasms, North and Central America, Diagnostics and Screening.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

Companies

The University of Western Ontario

Places

Central America
North America
Canada
United States
Americas
Ontario
London

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
            Urological Diseases
      Medical Specialties and Practices
            Urology